Form 4: USANA Director Sells Entire Stock Holding

USANA Health Sciences Director Gilbert A. Fuller plans to sell all 1,058 shares of common stock on August 7, 2025, at $29.1014 per share.

Summary

• Gilbert A. Fuller, a Director of USANA Health Sciences Inc. (USNA), reported a planned sale of common stock.
• The transaction involves the disposition of 1,058 shares of USANA common stock.
• The sale is scheduled to occur on August 7, 2025, at a price of $29.1014 per share.
• Following this transaction, Mr. Fuller will beneficially own 0 shares of USANA common stock.
• The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged sale.

Sentiment

Score: 3

Explanation: The sentiment is negative due to a director selling their entire stake in the company, which can signal a lack of confidence, despite the transaction being pre-planned under a 10b5-1 plan.

Positives

• The transaction is pre-planned under a Rule 10b5-1(c) plan, which can reduce concerns about insider trading based on non-public information.

Negatives

• A director selling their entire stake (1,058 shares resulting in 0 beneficial ownership) could be perceived negatively by the market, potentially signaling a lack of confidence in the company's future prospects from an insider's perspective.

Future Outlook

NA

Industry Context

Insider sales, especially by directors, are closely watched in the market as they can signal management's perception of the company's valuation or future. This specific sale by a director to zero beneficial ownership is a notable event within the health sciences industry, where insider confidence can influence investor sentiment.

Comparison to Industry Standards

• Insider selling is a common occurrence across all industries, but a director reducing their beneficial ownership to zero is less common and can be viewed more critically than partial sales.
• Compared to other health and wellness companies, significant insider sales can sometimes precede periods of underperformance or indicate a belief that the stock is fully valued.

Stakeholder Impact

• Shareholders: May interpret the full divestment by a director as a negative signal, potentially leading to downward pressure on the stock price.
• Employees: No direct impact mentioned, but general market sentiment could indirectly affect morale.

Key Dates

Recommendation

The complete divestment of shares by a director, resulting in zero beneficial ownership, is a strong negative signal from an insider. While the transaction is pre-planned under a 10b5-1 plan, the decision to sell all shares suggests a lack of long-term conviction in the company's future performance or current valuation from a key insider. This action could lead to negative market sentiment and potential downward pressure on the stock.

Keywords

USANA Health Sciences, USNA, Insider Sale, Form 4, Director Stock Sale, Gilbert A Fuller, Rule 10b5-1